{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:52:12Z","timestamp":1781826732246,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T00:00:00Z","timestamp":1743033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["121677\/2022-2"],"award-info":[{"award-number":["121677\/2022-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"National Council for Scientific and Technological Development","doi-asserted-by":"publisher","award":["310168\/2022-8"],"award-info":[{"award-number":["310168\/2022-8"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2021\/11295-8"],"award-info":[{"award-number":["2021\/11295-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2019\/04683-1"],"award-info":[{"award-number":["2019\/04683-1"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"State of Sao Paulo Research Foundation","doi-asserted-by":"publisher","award":["2018\/26166-6"],"award-info":[{"award-number":["2018\/26166-6"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordination of Higher Education Personnel Improvement","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.biopha.2025.118024","type":"journal-article","created":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T07:34:27Z","timestamp":1743665667000},"page":"118024","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Evaluation of hypoxia-inducible factor-1 and 2 alpha inhibitory compounds in the oral cavity and pharyngeal cancer"],"prefix":"10.1016","volume":"186","author":[{"given":"Bianca Barb\u00e9rio Bogdan","family":"Tedeschi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Henrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula Simedan","family":"Vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Helena","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Sayoko","family":"Kawasaki-Oyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9rika Cristina","family":"Pavarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peterson","family":"de Jesus Morais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vit\u00f3ria Scavacini","family":"Possebon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vilson Serafim","family":"J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia Maria Urbanin","family":"Castanhole-Nunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2622-4673","authenticated-orcid":false,"given":"Eny Maria","family":"Goloni-Bertollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2025.118024_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1056\/NEJMra1715715","article-title":"Head and Neck Cancer","volume":"382","author":"Chow","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biopha.2025.118024_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.oraloncology.2014.01.016","article-title":"International trends in head and neck cancer incidence rates: differences by country, sex, and anatomic site","volume":"50","author":"Simard","year":"2014","journal-title":"Oral. Oncol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118024_bib3","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.coms.2018.06.001","article-title":"Epidemiology and demographics of the head and neck cancer population","volume":"30","author":"Cohen","year":"2018","journal-title":"Oral. Maxillofac. Surg. Clin. North Am."},{"issue":"2","key":"10.1016\/j.biopha.2025.118024_bib4","first-page":"115","article-title":"Does recreational drug use influence survival and morbidity associated with laryngeal cancer?","volume":"14","author":"Woodley","year":"2022","journal-title":"Addict. Health"},{"issue":"9","key":"10.1016\/j.biopha.2025.118024_bib5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41415-022-5166-x","article-title":"Reviewing the epidemiology of head and neck cancer: definitions, trends, and risk factors","volume":"233","author":"Gormley","year":"2022","journal-title":"Br. Dent. J."},{"issue":"1","key":"10.1016\/j.biopha.2025.118024_bib6","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118024_bib7","doi-asserted-by":"crossref","first-page":"7819","DOI":"10.1038\/srep07819","article-title":"Identification of molecular signature of head and neck cancer stem-like cells","volume":"5","author":"Shrivastava","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118024_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3389\/fbioe.2019.00292","article-title":"Hypoxia-conditioned mesenchymal stem cell-derived extracellular vesicles induce increased vascular tube formation","volume":"7","author":"Almeria","year":"2019","journal-title":"Front Bioeng. Biotechnol."},{"issue":"4","key":"10.1016\/j.biopha.2025.118024_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"issue":"9","key":"10.1016\/j.biopha.2025.118024_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cells10092371","article-title":"HIF-1-independent mechanisms regulating metabolic adaptation in hypoxic cancer cells","volume":"10","author":"Lee","year":"2021","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.biopha.2025.118024_bib11","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.biopha.2025.118024_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00268-017-4331-x","article-title":"Hypoxia increases thyroid cancer stem cell-enriched side population","volume":"42","author":"Mahkamova","year":"2018","journal-title":"World J. Surg."},{"issue":"5","key":"10.1016\/j.biopha.2025.118024_bib13","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1111\/1440-1681.13247","article-title":"Cancer stemness contributes to the cluster formation of colon cancer cells and high metastatic potentials","volume":"47","author":"Kapeleris","year":"2020","journal-title":"Clin. Exp. Pharm. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118024_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10585-018-9951-5","article-title":"Sema4D expression and secretion are increased by HIF-1\u03b1 and inhibit osteogenesis in bone metastases of lung cancer","volume":"36","author":"Chen","year":"2019","journal-title":"Clin. Exp. Metastas."},{"issue":"6","key":"10.1016\/j.biopha.2025.118024_bib15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00428-013-1484-3","article-title":"Expression of hypoxia-inducible factor 1 alpha in papillary thyroid carcinoma is associated with desmoplastic stromal reaction and lymph node metastasis","volume":"463","author":"Kopereck","year":"2013","journal-title":"Virchows Arch."},{"issue":"3","key":"10.1016\/j.biopha.2025.118024_bib16","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12600","article-title":"Hypoxia promotes vasculogenic mimicry formation by vascular endothelial growth factor A mediating epithelial-mesenchymal transition in salivary adenoid cystic carcinoma","volume":"52","author":"Wang","year":"2019","journal-title":"Cell Prolif."},{"issue":"12","key":"10.1016\/j.biopha.2025.118024_bib17","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/carcin\/15.12.2683","article-title":"MTS1\/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma","volume":"15","author":"Yeudall","year":"1994","journal-title":"Carcinogenesis"},{"issue":"1","key":"10.1016\/j.biopha.2025.118024_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R","article-title":"A new human cell line (FaDu) from a carcinoma hypopharyngeal","volume":"29","author":"Rangan","year":"1972","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.biopha.2025.118024_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105633","article-title":"From tissue physoxia to cancer hypoxia, cost-effective methods to study tissue-specific O","volume":"23","author":"Nascimento-Filho","year":"2022","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2025.118024_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/genes13020282","article-title":"ALS. MiR-612, miR-637, and miR-874 can regulate VEGFA expression in hepatocellular carcinoma cell lines","volume":"13","author":"Castanhole-Nunes","year":"2022","journal-title":"Genes"},{"issue":"7","key":"10.1016\/j.biopha.2025.118024_bib21","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1158\/1535-7163.MCT-07-2059","article-title":"Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha","volume":"7","author":"Puppo","year":"2008","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118024_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0022-2836(03)00670-3","article-title":"Protein-protein docking with simultaneous optimization of rigid-body displacement and side-chain conformations","volume":"331","author":"Gray","year":"2003","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2025.118024_bib23","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/med.21771","article-title":"The role of hypoxia-inducible factor 1 in tumor immune evasion","volume":"41","author":"You","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2025.118024_bib24","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1080\/17460441.2019.1613370","article-title":"The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy","volume":"14","author":"Albadari","year":"2019","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.biopha.2025.118024_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.145796","article-title":"Up-down regulation of HIF-1\u03b1 in cancer progression","volume":"798","author":"Rashid","year":"2021","journal-title":"Gene"},{"issue":"5","key":"10.1016\/j.biopha.2025.118024_bib26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/carcin\/bgu004","article-title":"Inhibition of hypoxia-inducible factors limits tumor progression in a mouse model of colorectal cancer","volume":"35","author":"Shay","year":"2014","journal-title":"Carcinogenesis"},{"issue":"3","key":"10.1016\/j.biopha.2025.118024_bib27","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.18632\/oncotarget.6490","article-title":"Inhibition of hypoxia-inducible factor 1 and topoisomerase with acriflavine sensitizes perihilar cholangiocarcinomas to photodynamic therapy","volume":"7","author":"Weijer","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.biopha.2025.118024_bib28","first-page":"3549","article-title":"Antitumor activity of acriflavine in human hepatocellular carcinoma cells","volume":"34","author":"Lee","year":"2014","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.biopha.2025.118024_bib29","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tranon.2016.11.008","article-title":"Acriflavine inhibits acquired drug resistance by blocking the epithelial-to-mesenchymal transition and the unfolded protein response","volume":"10","author":"Dekervel","year":"2017","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.biopha.2025.118024_bib30","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.omtn.2022.01.016","article-title":"DNA topoisomerase inhibition with the HIF inhibitor acriflavine promotes transcription of lncRNAs in endothelial cells","volume":"27","author":"Seredinski","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"15","key":"10.1016\/j.biopha.2025.118024_bib31","first-page":"4316","article-title":"Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway","volume":"62","author":"Rapisarda","year":"2002","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.biopha.2025.118024_bib32","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation, and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2025.118024_bib33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuint.2019.03.008","article-title":"Pharmacological HIF inhibition prevents retinal neovascularization with improved visual function in a murine oxygen-induced retinopathy model","volume":"128","author":"Miwa","year":"2019","journal-title":"Neurochem. Int."},{"issue":"7","key":"10.1016\/j.biopha.2025.118024_bib34","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1158\/1535-7163.MCT-09-0274","article-title":"Increased antitumor activity of bevacizumab in combination with hypoxia-inducible factor-1 inhibition","volume":"8","author":"Rapisarda","year":"2009","journal-title":"Mol. Cancer Ther."},{"issue":"1","key":"10.1016\/j.biopha.2025.118024_bib35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpedsurg.2012.10.016","article-title":"HIF-1\u03b1 activation mediates resistance to anti-angiogenic therapy in neuroblastoma xenografts","volume":"48","author":"Hartwich","year":"2013","journal-title":"J. Pediatr. Surg."},{"issue":"1","key":"10.1016\/j.biopha.2025.118024_bib36","first-page":"697","article-title":"Resveratrol integrates metabolic and growth effects in PC3 prostate cancer cells-involvement of prolyl hydroxylase and hypoxia-inducible factor-1","volume":"17","author":"Fonseca","year":"2019","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.biopha.2025.118024_bib37","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/nyas.12837","article-title":"Resveratrol in the treatment of pancreatic cancer","volume":"1348","author":"Xu","year":"2015","journal-title":"Ann. N. Y Acad. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2025.118024_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112126","article-title":"Resveratrol binds and inhibits transcription factor HIF-1\u03b1 in pancreatic cancer","volume":"394","author":"Srivani","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.biopha.2025.118024_bib39","doi-asserted-by":"crossref","first-page":"8970","DOI":"10.12659\/MSM.913290","article-title":"Resveratrol induces apoptosis in murine prostate cancer cells via hypoxia-inducible factor 1-alpha (HIF-1\u03b1)\/reactive oxygen species (ROS)\/P53 signaling","volume":"24","author":"Wang","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.biopha.2025.118024_bib40","first-page":"1","article-title":"SiRNA: mechanism of action, challenges, and therapeutic approaches","volume":"905","author":"Alshaer","year":"2020","journal-title":"Eur. J. Pharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225002185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T23:03:36Z","timestamp":1781823816000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225002185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":40,"alternative-id":["S0753332225002185"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118024","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of hypoxia-inducible factor-1 and 2 alpha inhibitory compounds in the oral cavity and pharyngeal cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118024"}}